Furthermore, the availability of an inducible SMA Cre allowed us to transiently deplete Runx2 specifically from the aVICs and sinus wall cells at an early stage of the disease, thus allowing us to determine whether Runx2 was required for CAVD progression. Here, RUNX2 is linked to congenital bilateral aplasia of vas deferens from CFTR mutation.